Objective: To describe a movement disorder characterized by ocular flutter, trunk ataxia, and mild generalized myoclonus associated with anti-GQ1b antibodies.
O

CULAR FLUTTER IS A RARE
oculomotor syndrome that is clinically defined by intermittent bursts of involuntary conjugate eye oscillations with a strict preponderance for the horizontal plane and without intersaccadic interval. 1 Ocular flutter has been considered to be a subform of opsoclonus, probably caused by a loss of tonic stimulation of omnipause neurons. 2 In the healthy brain, omnipause neurons inhibit burst neurons within the paramedian pontine reticular formation responsible for conjugate horizontal eye movements and cease to discharge before and during saccadic eye movements. 2 Although our current understanding of the pathophysiology of ocular flutter is incomplete, this syndrome appears to originate from a loss of omnipause neuron inhibition on burst neurons within the paramedian pontine reticular formation.
1,2 A recent case of ocular flutter after a circumscribed pontine lesion due to multiple sclerosis strongly supports the role of the paramedian pontine reticular formation within the current pathophysiological concept of ocular flutter. 3 
Cogan
4 and Baringer and colleagues 5 are credited for the first descriptions of a movement disorder characterized by brief jerks of conjugated eye movements and postural body tremor. Although ocular flutter and opsoclonus probably share a common pathophysiology, the syndromes are clinically distinct. Whereas the conjugate oscillations of the eyes are strictly horizontal in ocular flutter, irregular oscillations in both the horizontal and vertical planes are observed in opsoclonus.
1,2 Hankey and Sadka 6 reported a case of ocular flutter associated with postural body tremor and trunk ataxia. In each of these early descriptions, cerebrospinal fluid examination revealed a mild lymphocytic pleocytosis, suggesting a parainfectious origin. Despite the frequent lack of direct serological evidence, the etiology of ocular flutter has been Video available online at www.archneurol.com associated with postinfectious autoimmune processes after infection with viruses, 5-10 such as the mumps virus, 5 enterovirus, 8 cytomegalovirus, 9 and the AIDS virus. 10 However, ocular flutter has also been reported to be associated with several forms of cancer, such as breast cancer 10 and small-cell lung cancer.
11,12
We report a movement disorder characterized by ocular flutter, trunk ataxia, and mild generalized myoclonus associated with anti-GQ1b antibodies. Our case description strengthens the autoimmune response hypothesis of this rare syndrome.
REPORT OF A CASE
Three days before admission, a 37-year-old woman developed brief paroxysmal episodes of blurred vision, illusions of horizontal external motion (oscillopsia), dizziness, gait imbalance, and occasional arrhythmic muscle jerks (myoclonus) most pronounced at the neck. The jerks ceased when she lay down in a recumbent position and were provoked by sitting up, standing, or walking. Truncal instability was already present when sitting up. The onset of these symptoms had been preceded by a generalized feeling of discomfort, loss of appetite, and a febrile infection of the upper respiratory tract with a sore throat for 2 weeks.
Neurological examination on admission revealed periodic, rapid, conjugated oscillations of the eyes with a strict preponderance for the horizontal plane (ocular flutter). The eye oscillations were independent of eye position and occurred during fixation (voluntary and guided changes in gaze position), regardless of gaze direction, with eyes open or closed (a video is available at http: //www.archneurol.com). The patient had full-range conjugated ocular motion and did not report diplopia. A mildstimulus sensitive myoclonus (which was most pronounced at the neck and provoked by sitting or standing) as well as mild ataxia of the trunk and gait in the absence of limb ataxia were evident (a video is available at http://www.archneurol.com). The myoclonus was relieved when the patient was in a recumbent position. The remainder of the neurological examination results were unremarkable. Clinical symptom severity increased within 1 week of admission, with the horizontal eye oscillations being more frequent (a video is available at http: //www.archneurol.com) and ataxia of the trunk and gait being more pronounced.
Red and white blood cell counts and biochemistry were normal on admission. Cerebrospinal fluid examination on admission revealed a normal opening pressure and mild pleocytosis (75 lymphocytes/mm 3 ). Cerebrospinal fluid protein, lactate, and glucose levels were within the normal range. Oligoclonal bands were positive and quantitative cerebrospinal fluid IgG and IgM indexes were positive. Results of a cerebrospinal fluid examination repeated 10 days later were unremarkable (3 lymphocytes/mm 3 ). Brain magnetic resonance imaging, including 2-mm sections through the brainstem and the cerebellum, showed no abnormality before or following application of gadolinium-diethylenetriamine pentaacetic acid. Analysis of ocular movements using electrooculography revealed bursts of rapid horizontal, symmetric, and sinusoidal movements without intersaccadic interval (Figure) . Results of electrophysiological examinations, such as somatosensory, acoustic, and visual evoked potentials and electroencephalography, were normal. Results of duplex Doppler ultrasonography of the extracranial and intracranial vessels were also normal.
Serological tests, cultures, and polymerase chain reactions performed on blood and cerebrospinal fluid samples were negative for viral, bacterial, and fungal infections. Results of screening examinations for neoplasms, including abdominal ultrasonography, computed tomography of the abdomen and chest, as well as whole-body fludeoxyglucose F18 positron emission tomography, were all unremarkable. Serological tests of blood and cerebrospinal fluid for paraneoplastic antibodies, such as anti-Ri (ANNA-2), anti-Hu (ANNA-1), anti-Yo (PCA1), antiMa2, anti-CV2 (collapsin response mediator protein 5), and anti-amphiphysin, were negative. Ganglioside antibodies were negative for GM1, GM2, GM3, GD1a, GD1b, GD3, GT1a, GT1b, GT3, and asialo GM1. IgG and IgM antibodies against GQ1b were found.
The patient was initially treated with acyclovir (750 mg, 3 times a day intravenously) and ceftriaxone (2000 mg once a day intravenously) for 14 days. Prednisolone acetate (1000 mg once a day intravenously) was given to the patient for 5 days together with the antiviral and antibiotic therapy and then was switched for an oral regimen (100 mg once a day orally) for 11 days. Plasmapheresis therapy began 21 days after admission, with daily immunoadsorption of 500 mL of plasma for 2 days but had to be discontinued owing to low fibrinogen levels. 
